VEGFA and osteosarcoma: In the current study, G‐Rg5 showed strong binding energy with VEGFA (−8.4 kcal/mol), which suggested that G‐Rg5 could potentially inhibit the activity of VEGFA and VEGFA‐related pathways, and therefore suppress osteosarcoma growth and metastasis.